N-Glycolyl-ganglioside GM3 (NeuGc-GM3) is a ganglioside GM3 with an N-glycolylated sialic acid (NeuGc). It can be used in a number of cancer research, including breast and lung cancers, as well as pediatric tumors.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.